{"id":"W3092141337","doi":"10.1016/j.intimp.2020.107026","title":"Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway","year":2020,"lang":"en","type":"article","venue":"International Immunopharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Xunta de Galicia; Innovative Medicines Initiative; Debreceni Egyetem; Ministero dello Sviluppo Economico; Ministerio de Ciencia e Innovación; Ministerio de Economía y Competitividad; Novartis Pharma; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Ministerio de Ciencia, Innovación y Universidades; Wellcome Trust; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Boehringer Ingelheim; Janssen Pharmaceuticals; Merck KGaA; European Regional Development Fund; Meso Scale Diagnostics; AbbVie; Takeda Pharmaceutical Company; Pfizer","keywords":"Proinflammatory cytokine; Chemokine; Chemistry; Cytokine; Interleukin 17; Pharmacology; Drug discovery; Virtual screening; Immunology; Inflammation; Biology; Biochemistry; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003259692,0.0002956377,0.0003915356,0.00008865168,0.0002118618,0.00002951177,0.00097879,0.0002444715,0.001253064],"category_scores_gemma":[0.0001308327,0.000210931,0.0002751886,0.0001748846,0.0004133166,0.0002583738,0.0003578608,0.0004453165,0.0003427251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006734052,"about_ca_system_score_gemma":0.0001268766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002209388,"about_ca_topic_score_gemma":9.774172e-7,"domain_scores_codex":[0.9982688,0.0001742891,0.0006861251,0.0003830767,0.0001056323,0.0003820792],"domain_scores_gemma":[0.9987203,0.0005102109,0.0003873923,0.0001709197,0.0001808021,0.00003031634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001283504,0.0003448173,0.001259436,0.00001058632,0.001442318,0.00002720464,0.0005615086,0.0001037657,0.9831023,0.0009106559,0.008827784,0.002126149],"study_design_scores_gemma":[0.005446144,0.0002749176,0.004662995,0.00001297086,0.0001879061,0.00004350126,0.0002817474,0.0001390513,0.8868862,0.00002793996,0.1017797,0.0002568615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861276,0.003828976,0.0001874328,0.004310979,0.003725326,0.0003522967,0.0002615114,0.0001329438,0.00107294],"genre_scores_gemma":[0.9948966,0.0004463393,0.00007304155,0.002436605,0.0003194764,0.0001067918,0.0001682408,0.00003286736,0.001520054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09621604,"threshold_uncertainty_score":0.9996599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02488114799132078,"score_gpt":0.2705651862935972,"score_spread":0.2456840383022764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}